About Kriya Formulations Private Limited
Data last updated:
Kriya Formulations Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85320KA2017PTC106072. Its GSTIN is 29AAGCK7500C1ZR (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinay Achanta and Achanta Krishna Priya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No 779/1 Opp: Keb Office Thilak Nagar Sarjapura Road Attibele Town Anekal, Bangalore, Karnataka, India – 562107.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.02 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹2.98 Lakh (net margin 2.9%) and EBITDA of ₹11.85 Lakh (EBITDA margin 11.6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kriyaformulations.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo 779/1 Opp: Keb Office Thilak Nagar Sarjapura Road Attibele Town Anekal, Bangalore, Karnataka, India – 562107
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kriya Formulations Private Limited
The main business activity of Kriya Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kriya Formulations Private Limited FY 2024 filings available
Kriya Formulations Private Limited reported revenue of ₹1.02 Cr (down 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Kriya Formulations Private Limited
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kriya Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.98 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kriya Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kriya Formulations are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kriya Formulations Private Limited
Kriya Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sarvit Life Sciences Private Limited | ₹1.03 Cr (FY 2017) | •••• | •••• | -27.0% | •••• | Chandigarh, India |
| Pusilin Biotechnology Private Limited | ₹1.03 Cr (FY 2024) | •••• | •••• | -83.0% | •••• | Kanpur, Uttar Pradesh, India |
| Biospace Lifesciences Private Limited | ₹1.03 Cr (FY 2025) | •••• | •••• | -40.0% | •••• | Varanasi, Uttar Pradesh, India |
| DRS Biopharma Private Limited | ₹1.03 Cr (FY 2025) | •••• | •••• | 163.0% | •••• | Chennai, Tamil Nadu, India |
| Nucleus Biosciences Private Limited | ₹1.03 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Ahmedabad, Gujarat, India |
| Kriya Formulations Private Limited this company | ₹1.02 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Bangalore, Karnataka, India |
| Exciller Wellness Private Limited | ₹1.02 Cr (FY 2024) | •••• | •••• | 190.0% | •••• | Ahmedabad, Gujarat, India |
| C W C Pharmaceuticals Pvt. Ltd. | ₹1.02 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Haryana, India |
| Pujyate Medicare (OPC) Private Limited | ₹1.02 Cr (FY 2024) | •••• | •••• | 477648.0% | •••• | Bhubaneswar, Odisha, India |
| Alleviate Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Panchkula, Haryana, India |
| Bengaluru Biomedicals Private Limited | ₹1.02 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Kriya Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kriya Formulations Private Limited
Kriya Formulations Private Limited is audited by Ashok and Vanraj for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ashok and Vanraj | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kriya Formulations Private Limited
Kriya Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinay Achanta | Director | 04 Sep 2017 | 9 Years 1 Months | Current |
| Achanta Krishna Priya | Director | 04 Sep 2017 | 9 Years 1 Months | Current |
Ownership and Shareholding of Kriya Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kriya Formulations Private Limited
Kriya Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kriya Formulations Private Limited
Employment history and EPFO contributions of people linked to Kriya Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kriya Formulations Private Limited
Kriya Formulations Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Achanta Krishna Priya was appointed as Director on 04 Sep 2017.
Credit Ratings, Litigation & Regulatory Alerts for Kriya Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kriya Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kriya Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kriya Formulations Private Limited
Kriya Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCK7500C1ZR | Karnataka | Active | 28 Sep 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kriya Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kriya Formulations Private Limited
Kriya Formulations is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 September 2017 (9+ years old) and is registered under CIN U85320KA2017PTC106072.
Kriya Formulations reported revenue of ₹1.02 Cr for FY 2024 (down 4% YoY).
Kriya Formulations has 2 current directors:
- Vinay Achanta - Director
- Achanta Krishna Priya - Director
Kriya Formulations reported a net profit of ₹2.98 Lakh (net margin 2.9%) and EBITDA of ₹11.85 Lakh (EBITDA margin 11.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kriya Formulations is 9% over three years and 9% over five years. In the latest year (FY 2024) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kriya Formulations is 29AAGCK7500C1ZR, registered in Karnataka.
The CIN (Corporate Identification Number) of Kriya Formulations is U85320KA2017PTC106072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kriya Formulations was incorporated on 04 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Kriya Formulations by revenue are Sarvit Life Sciences Private Limited, Pusilin Biotechnology Private Limited, Biospace Lifesciences Private Limited, DRS Biopharma Private Limited, Nucleus Biosciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Achanta Krishna Priya was appointed as Director on 04 Sep 2017. Vinay Achanta was appointed as Director on 04 Sep 2017.
Kriya Formulations can be reached through the website kriyaformulations.com. Its registered office is in Bangalore, Karnataka, India.